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Letters to the
Editor
Surgical damage of the saphenous
vein and graft patency
To the Editor:
It is 37 years since Favarolo’s article1
introducing the saphenous vein as a by-
pass graft appeared in the Journal of Tho-
racic and Cardiovascular Surgery. A
novel “no-touch” technique of preparing
this vessel has been described,2 and the
long-term follow-up study recently re-
ported in the Journal shows that, with
this technique, the patency rate of the
saphenous vein may be improved to a
rate equal to that of the internal thoracic
artery.3 Although the saphenous vein is
the most commonly used conduit for cor-
onary artery bypass grafting, its patency
rate is poor, with 15% to 30% of grafts
occluding in the first year and over 50%
within 10 years.4 Along with many oth-
ers, as basic research scientists, we are
surprised by the degree of damage in-
flicted on the saphenous vein during con-
ventional bypass surgery. It seems, when
harvesting this vessel as a graft, many
surgeons are in effect preparing a “tube”
or “pipe” (common definitions of con-
duit) with no regard to its many vital
vascular structures. The contribution of
tissue damage to graft occlusion has been
recognized for some time, and various
attempts at reducing surgical trauma have
been introduced, ranging from the use of
a system of “bent rod of rubber and su-
tures”5 to the use of local vasodilators6
and the “Souza no-touch technique.”2
In conventional methods of harvest-
ing, the vein is isolated from its sur-
rounding connective tissue, trauma that
causes a high proportion of vessels to go
into spasm. Although vasodilators may
be used to overcome spasm, high-pres-
sure intraluminal distention is mostly
used, resulting in damage to the luminal
endothelium (Figure 1). This influences
endothelium-derived factors, such as ni-
tric oxide, affecting vessel tone, cell pro-
liferation, and thrombus formation.6 In
addition, the width of the vein wall is
markedly reduced (Figure 1) and the vas-
cular smooth muscle cells are distorted.
Last, the outer vessel wall layer, the ad-
ventitia, is generally removed or dam-
aged during harvesting of the vein. This
may play an important part in the subse-
quent processes involved in graft occlu-
sion because the adventitia does not
merely provide structural support for the
media, but contains the vasa vasorum, a
microvascular network responsible for
the exchange of gases and supply of nu-
trients to the vein wall. Clearly, damage
to segments of the saphenous vein during
harvesting as a graft is inevitable. Al-
though this isolated segment of vein is
“disconnected” from its vascular bed, the
supply of blood to medial and adventitial
structures will be maintained by the ret-
rograde blood flow observed through the
vasa vasorum in “no-touch” vein grafts at
implantation.3 Furthermore, the connec-
tive tissue surrounding the vein when the
“Souza no-touch” technique is used may
act as a buffer against coronary arterial
hemodynamics, “protecting” the graft in
very much the same way that has been
suggested with the use of experimental
external stents.4
We propose that damage to the saphe-
nous vein during conventional coronary
artery bypass grafting is a major contri-
bution to graft failure and suggest that
improved patency may be achieved sim-
ply by reducing vascular damage by use
of less traumatic harvesting techniques.
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Restaging patients with N2 (stage IIIa)
non–small cell lung cancer after
neoadjuvant chemoradiotherapy: A
closer look at redo mediastinoscopy
To the Editor:
On the basis of the data obtained by the
analysis of 93 locally advanced cases of non–
small cell lung cancer clinically restaged after
induction therapy, Cerfolio and coworkers1
conclude that when repeat positron emission
tomography (PET)/computed tomography
(CT) is adopted either in the staging or
restaging process, the percentage decrease
in maximum standardized uptake value
(maxSUV) of the primary tumor and in-
volved lymph nodes is predictive of pathol-
ogy, but pathologic assessment is still re-
quired because persistently high maxSUV
“does not equate to residual cancer.” We
commend the authors for their valuable
study. Along the line of discussion, Cer-
folio and coworkers state that “repeat
mediastinoscopy often is inaccurate and
potentially dangerous, especially after
chest irradiation” and that endoscopic
ultrasonography– guided fine-needle as-
piration (EUS-FNA) biopsy, despite be-
ing more precise and accurate, is “avail-
able only in few centers.” We would like
to amicably address the authors on this
point on the basis of our own personal
experience and confidence with redo me-
diastinoscopy. Pathologic reassessment
of the mediastinum is strongly advisable
in the setting of induction therapy for
locally advanced non–small cell lung
cancer because persistent N2 disease her-
alds a poor prognosis.
Shortly after the introduction of me-
diastinoscopy, redo procedures were con-
sidered to be technically impossible be-
Figure 1. Vascular damage to saphenous vein harvested for coronary artery bypass
grafting. Representative micrographs are shown of conventional (CONV) and no-touch
(NT) preparations of the same vein from a patient undergoing bypass grafting. The top
panels show the general structural differences where the adventitia is removed from the
conventional vein segments and, as a result of saline distention, the intimal folds seen
in the “no-touch” vein are absent and the vessel wall thickness is reduced (elastic-van
Gieson staining). The middle panels indicate a continuous lining of endothelial cells
(CD31 immunostaining) in a “no-touch” vein segment, whereas there are regions of
endothelial denudation in the conventional sample (arrow). The bottom panels show
ultrastructural changes to the vasa vasorum at the adventitial/medial border where a
microvessel is contracted and there is clumping of red blood cells in the conventional
sample, whereas in “no-touch” veins the lumen is open. Original magnifications: top
panels 20, middle panels 100, bottom panels 3000. L, Lumen.
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